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http://djournal homepage: www.elsevier.com/locate/dibEditorial“Publish or perish”: Should this still be true
for your data?The past decades have witnessed an era of data explosion that touches almost every aspects of
modern science. Powerful technologies such as Next-gen DNA sequencing, high throughput/content
screening platforms, the Large Hadron Collider and more, routinely generate copious amounts of data.
At the same time, collaborations between different disciplines had never been so urgently needed to
provide new insights that otherwise would not be possible. We are in need of a revolution in
publication infrastructure towards supporting researchers with the means to preserve and gain access
to research output. In this context, Elsevier has proudly launched Data in Brief, an open access journal
that publishes data from a broad spectrum of disciplines including Biology, Chemistry, Economics,
Psychology and Physics. Data in Brief strives to provide a platform for researchers to easily share and
reuse each other's datasets, promote collaboration across disciplines and to showcase the beneﬁts of
data driven research.
I have personally experienced research in both academic and industrial settings. If I were asked to
single out one thing that impressed me most about pharmaceutical industry, it will be the systematic
approach the industry adopted for collecting research and clinical data. Bringing a drug to the market
heavily relies on the data collected during the research and development process. Once data are
generated in pharmaceutical institute, they are pooled into a centralized database together with very
detailed lab note descriptions of the protocols, experimental designs, and analysis. The pharmaceu-
tical industry has spared no efforts in centralizing data to facilitate decision-making as well as
innovation. For example, we collect hundreds of assay data around a speciﬁc compound and place
them in a single webpage to facilitate decision making on how to optimizing the lead compound. I can
easily pull out a complete raw dataset for an experiment done 20 years ago as my reference in
Novartis Institutes for BioMedical Research (NIBR).
The push for data sharing and archiving in academia is starting to pick up speed and could beneﬁt
from the lessons already learned in industry. It is still the case that data generated in an academic
setting may sit in the lab for decades without being published or known to the outside world, waiting
for a “story” that could never be completed. Personally, I still have a lot of interesting data from my
Ph.D. study yet to be published, which could have provided insights for other researchers to work on.
It is sad that “publish or perish” still holds true today when the information storage and sharing costs
almost nothing. Those “perished data” indeed posed a tremendous waste of the valuable time and
funding spent to collect them. It is my sincere hope that Data in Brief will provide a venue for
researchers from academia and industry to not only share their data, but also share their unique
experiences in data handling and archiving.09/$ - see front matter & 2014 The Author. Published by Elsevier Inc. This is an open access article under the CC BY
(http://creativecommons.org/licenses/by/4.0/).
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not assume we know what data can be useful to others, so Data in Brief welcomes submissions that
describe data from all research areas. With this in mind, we deeply appreciate the diversity of data
sources for Data in brief to incorporate, and allow great ﬂexibility on the formality of the dataset to be
accompanied with the body of data description, as long as they provide sufﬁcient clarity for
reproducibility and interpretation.
Data in brief currently publish papers from 1. Collaborating journals that encourage authors to
convert their supporting data into a Data in Brief article; these articles are editorially reviewed; and 2.
Directly submitted data articles which are sent for peer-review to verify the value and transparency of
the data. To meet the speed of data generation, we aim to streamline the writing/reviewing process in
order to minimize the barrier for authors to write up data articles while maximally preserving the
ﬁdelity of the data for the beneﬁt of reproducibility and future interpretation. Authors are asked to
create their data reports by following the downloadable Data in brief template. We ask for key
information such as Speciﬁcations and Value of the data, Experimental Design, Supplemental data,
etc. Peer reviewers for Data in Brief will verify that the articles provide sufﬁcient details on how data
were acquired, good reasons why the data are important, and that any base level analysis of the data is
well described and relevant computer code provided. Data articles do not provide interpretation. In
addition to original data articles submission, authors are very welcome to translate their research
article's supporting data into a Data in Brief to be co-published with their research article. In addition
to original data articles, we also consider (1) negative results data, (2) quality control data for
evaluating commercial products, and (3) perspectives and commentary articles.
We hope Data in brief can be part of the solution to ease the publication barriers for excellent data,
encourage data sharing and contribute to establishing community standards for data preservation and
sharing.Editor in Chief Data Brief
Hao-Ran Wang, Ph.D.
Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, MA 02139, USA
E-mail address: hao-ran.wang@novartis.comAvailable online 28 November 2014
